QIA.DE: Qiagen N.V. Stock Live Price Graph
Qiagen N.V. stock live price (Euro), charts and analysis. Get QIA.DE stock market news.
Qiagen N.V. (QIA.DE)
Loading chart...
About the company
QIAGEN N.V. delivers comprehensive "sample to insight" solutions globally, enabling the transformation of biological materials into valuable molecular insights. Their extensive product portfolio addresses various stages of molecular analysis, starting with primary sample technologies. This includes a range of consumables such as kits for nucleic acid stabilization and purification from initial biological samples, as well as manual and automated processing systems for applications like genotyping, gene expression, and viral or bacterial analysis, often utilizing advanced silica membrane and magnetic bead methodologies. They also supply components and kits for purifying nucleic acids from secondary sample types, alongside dedicated instruments and accessories for efficient nucleic acid purification. The company's broad suite of assays covers critical diagnostic and research areas. These include interferon-gamma release tests for tuberculosis, assays for post-transplant monitoring and viral load assessment, and solutions for prenatal testing, detection of sexually transmitted diseases, and human papillomavirus (HPV). Furthermore, QIAGEN provides assays for analyzing complex genomic variants, such as mutations, insertions, deletions, and fusions. For streamlined diagnostics, their "sample to insight" instruments facilitate one-step molecular analysis for challenging syndromes and integrate PCR testing capabilities. QIAGEN also develops and supplies an array of PCR consumables, including quantitative PCR, reverse transcription, and combination kits, essential for gene expression analysis, genotyping, and gene regulation studies. Their offerings extend to human identification and forensics, with STR assays and kits for food contamination detection. The company also features PCR instruments, including cutting-edge digital PCR solutions, and custom-developed OEM consumables. Further bolstering their capabilities, QIAGEN provides predefined and customizable Next-Generation Sequencing (NGS) gene panels, alongside library preparation kits, components, and whole genome amplification solutions. Complementing their vast selection of consumables and instruments, the company offers robust bioinformatics solutions and specialized custom laboratory and genomic services. Serving a diverse customer base, QIAGEN caters to molecular diagnostics laboratories, academic research institutions, pharmaceutical companies, and applied testing sectors. Strategic alliances are maintained with Sysmex Corporation, OncXerna Therapeutics, and Mirati. Founded in 1986, QIAGEN N.V. maintains its corporate headquarters in Venlo, the Netherlands.
Company profile
Market News & Analysis
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $0.3052 | $0.3052 | 7.06% | - |
| - | $2.1025 | $2.1025 | 5.61% | - |
| - | $0.212 | $0.212 | 3.22% | - |
| - | $1.1099 | $1.1099 | 2.62% | - |
| - | $1.0962 | $1.0962 | 2.73% | - |
What Is QIA.DE? Live QIA.DE Prices and Analysis
QIA.DE, or Qiagen N.V., is a prominent global provider of sample and assay technologies, serving the healthcare sector through molecular diagnostics, applied testing, academic research, and pharmaceutical development. The company is crucial in the life sciences sector, offering products that facilitate the rapid and accurate analysis of biological samples. Investors closely monitor Qiagen due to its innovative solutions and its role in addressing health challenges, particularly in diagnostics and personalized medicine.
As a publicly traded company on the Frankfurt Stock Exchange, QIA.DE has garnered significant attention from investors interested in the biotech and healthcare sectors. The company’s performance is often viewed as a barometer for trends in life sciences, especially amidst evolving global health challenges.
Frequently asked questions
What is the QIA.DE stock price?
The latest QIA.DE (Qiagen N.V. (QIA.DE)) stock price is 38.6950 EUR. Follow the live quote and chart on this page for real-time updates.
What are QIA.DE's intraday ceiling and floor prices?
For QIA.DE, the intraday ceiling is 38.7500 EUR and the floor is 37.9750 EUR. These levels may update during the session.
What is QIA.DE's previous closing price?
The previous closing price for QIA.DE is 38.4100 EUR.
What is QIA.DE's trading volume?
The current trading volume for QIA.DE is 650,451. Volume can change throughout the session.
Where can I see the live QIA.DE price?
You can follow the live QIA.DE (Qiagen N.V. (QIA.DE)) price in the quote area and chart at the top of this Investvio overview page.
Where can I see QIA.DE historical prices and charts?
The current price chart for QIA.DE (Qiagen N.V. (QIA.DE)) is on this overview page. For longer historical prices and archive data, open the Archive tab and choose a period to review past performance.